These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 19070497)
21. CoMFA and HQSAR studies on 6,7-dimethoxy-4-pyrrolidylquinazoline derivatives as phosphodiesterase10A inhibitors. Kulkarni SS; Patel MR; Talele TT Bioorg Med Chem; 2008 Apr; 16(7):3675-86. PubMed ID: 18299198 [TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors. Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250 [TBL] [Abstract][Full Text] [Related]
23. 3D-QSAR studies of heterocyclic quinones with inhibitory activity on vascular smooth muscle cell proliferation using pharmacophore-based alignment. Ryu CK; Lee Y; Park SG; You HJ; Lee RY; Lee SY; Choi S Bioorg Med Chem; 2008 Nov; 16(22):9772-9. PubMed ID: 18930405 [TBL] [Abstract][Full Text] [Related]
24. Synthesis, anti-tuberculosis activity and 3D-QSAR study of amino acid conjugates of 4-(adamantan-1-yl) group containing quinolines. Nayyar A; Patel SR; Shaikh M; Coutinho E; Jain R Eur J Med Chem; 2009 May; 44(5):2017-29. PubMed ID: 19022537 [TBL] [Abstract][Full Text] [Related]
25. Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: molecular modeling, CoMFA and CoMSIA studies. Trossini GH; Guido RV; Oliva G; Ferreira EI; Andricopulo AD J Mol Graph Model; 2009 Aug; 28(1):3-11. PubMed ID: 19376735 [TBL] [Abstract][Full Text] [Related]
26. Molecular modeling studies of N-substituted pyrrole derivatives--potential HIV-1 gp41 inhibitors. Teixeira C; Barbault F; Rebehmed J; Liu K; Xie L; Lu H; Jiang S; Fan B; Maurel F Bioorg Med Chem; 2008 Mar; 16(6):3039-48. PubMed ID: 18226912 [TBL] [Abstract][Full Text] [Related]
27. [Synthesis and vasorelaxant activities of benzopyran-4-one hydrazone derivatives]. Zhao SY; Huang WL; Zhang HB Yao Xue Xue Bao; 2002 Aug; 37(8):621-5. PubMed ID: 12567776 [TBL] [Abstract][Full Text] [Related]
28. 3D-QSAR CoMFA of a series of DABO derivatives as HIV-1 reverse transcriptase non-nucleoside inhibitors. de Brito MA; Rodrigues CR; Cirino JJ; de Alencastro RB; Castro HC; Albuquerque MG J Chem Inf Model; 2008 Aug; 48(8):1706-15. PubMed ID: 18671385 [TBL] [Abstract][Full Text] [Related]
29. 3D-QSAR CoMFA studies on bis-coumarine analogues as urease inhibitors: a strategic design in anti-urease agents. Zaheer-ul-Haq ; Lodhi MA; Ahmad Nawaz S; Iqbal S; Mohammed Khan K; Rode BM; Atta-ur-Rahman ; Choudhary MI Bioorg Med Chem; 2008 Mar; 16(6):3456-61. PubMed ID: 18280742 [TBL] [Abstract][Full Text] [Related]
30. Molecular modeling of some 1H-benzimidazole derivatives with biological activity against Entamoeba histolytica: a comparative molecular field analysis study. López-Vallejo F; Medina-Franco JL; Hernández-Campos A; Rodríguez-Morales S; Yépez L; Cedillo R; Castillo R Bioorg Med Chem; 2007 Jan; 15(2):1117-26. PubMed ID: 17074492 [TBL] [Abstract][Full Text] [Related]
31. A 3D linear solvation energy model to quantify the affinity of flavonoid derivatives toward P-glycoprotein. Boccard J; Bajot F; Di Pietro A; Rudaz S; Boumendjel A; Nicolle E; Carrupt PA Eur J Pharm Sci; 2009 Feb; 36(2-3):254-64. PubMed ID: 18955135 [TBL] [Abstract][Full Text] [Related]
32. CoMFA and CoMSIA studies on thiazolidin-4-one as anti-HIV-1 agents. Murugesan V; Prabhakar YS; Katti SB J Mol Graph Model; 2009 Feb; 27(6):735-43. PubMed ID: 19117780 [TBL] [Abstract][Full Text] [Related]
33. Ordinal classification using Comparative Molecular Field Analysis. Ohgaru T; Shimizu R; Okamoto K; Kawase M; Shirakuni Y; Nishikiori R; Takagi T J Chem Inf Model; 2008 Jan; 48(1):207-12. PubMed ID: 18161957 [TBL] [Abstract][Full Text] [Related]
34. [Design, synthesis and vasorelaxant activity of R, S-1-(substituted phenyl)-4-[3-(naphtha-1-yl-oxy)-2-hydroxypropyl]-piperazine derivatives]. Fu XZ; Tang L; Yuan M; Shi JS Yao Xue Xue Bao; 2007 Jul; 42(7):735-40. PubMed ID: 17882957 [TBL] [Abstract][Full Text] [Related]
35. Beta-amino acid substitutions and structure-based CoMFA modeling of hepatitis C virus NS3 protease inhibitors. Nurbo J; Peterson SD; Dahl G; Helena Danielson U; Karlén A; Sandström A Bioorg Med Chem; 2008 May; 16(10):5590-605. PubMed ID: 18434166 [TBL] [Abstract][Full Text] [Related]
36. Investigation of structural requirements for inhibitory activity at the rat and housefly picrotoxinin binding sites in ionotropic GABA receptors using DISCOtech and CoMFA. Ju XL; Hao YL; Pei JF; Ozoe Y Chemosphere; 2007 Oct; 69(6):864-71. PubMed ID: 17675213 [TBL] [Abstract][Full Text] [Related]
38. 'Sum of activities' as dependent parameter: a new CoMFA-based approach for the design of pan PPAR agonists. Sundriyal S; Bharatam PV Eur J Med Chem; 2009 Jan; 44(1):42-53. PubMed ID: 18448203 [TBL] [Abstract][Full Text] [Related]
39. Comparative molecular field analysis of quinoline derivatives as selective and noncompetitive mGluR1 antagonists. Sekhar YN; Nayana MR; Ravikumar M; Mahmood SK Chem Biol Drug Des; 2007 Dec; 70(6):511-9. PubMed ID: 18005334 [TBL] [Abstract][Full Text] [Related]
40. Natural flavonoid derivatives as oral human epidermoid carcinoma cell inhibitors. Gunda SK; Kongaleti SF; Shaik M Int J Comput Biol Drug Des; 2015; 8(1):19-39. PubMed ID: 25869317 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]